ProfileGDS5678 / 1429605_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 59% 57% 57% 58% 57% 60% 59% 57% 57% 57% 57% 57% 58% 57% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.571359
GSM967853U87-EV human glioblastoma xenograft - Control 23.4685757
GSM967854U87-EV human glioblastoma xenograft - Control 33.4447657
GSM967855U87-EV human glioblastoma xenograft - Control 43.4463158
GSM967856U87-EV human glioblastoma xenograft - Control 53.4125257
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.6542260
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.6412659
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4531757
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4331757
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4585957
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.4548457
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4384757
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.513958
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4596357